---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-000669"
form_type: "8-K"
ticker: "AZTA"
cik: "0000933974"
company_name: "Azenta, Inc."
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T14:33:45.030723+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Azenta realigns into three segments and provides historical recast data

## Summary
- Effective Oct 1, 2023, Azenta restructured into Multiomics, Sample Management Solutions, and B Medical Systems.
- Multiomics offers genomic analysis, gene sequencing, and gene synthesis under a single business unit.
- Sample Management Solutions combines Sample & Repository, Ultracold Systems, and Consumables & Instruments.
- Historical segment data for FY2023 and FY2022 recast to reflect the new structure are provided in Exhibit 99.1.
- No specific financial numbers are available in the filing text; recast data requires review of the exhibit.

## SEC filing metadata
- accession: 0001558370-24-000669
- form_type: 8-K
- ticker: AZTA
- cik: 0000933974
- company_name: Azenta, Inc.
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933974/000155837024000669/0001558370-24-000669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933974/000155837024000669/azta-20240131x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-000669
- JSON: https://secwatch.observer/filing/0001558370-24-000669.json
- Plain text: https://secwatch.observer/filing/0001558370-24-000669.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.